medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2012, Número 05-06

<< Anterior Siguiente >>

Medicina & Laboratorio 2012; 18 (05-06)


Manifestaciones dermatológicas de las enfermedades hepáticas: un enfoque para el médico general

Espinoza HYP, Molina VV, Restrepo GJC

Idioma: Español
Referencias bibliográficas: 51
Paginas: 229-238
Archivo PDF: 490.26 Kb.


RESUMEN

las enfermedades hepáticas tienen manifestaciones cutáneas hasta en el 15% al 20% de los casos. Pueden ser muy variadas y ninguna de ellas es patognomónica; sin embargo, su reconocimiento puede ser la base para el inicio de estudios, así como para la primera aproximación hacia la etiología de la hepatopatía. En este artículo se describen las principales manifestaciones cutáneas de las enfermedades hepáticas incluyendo la ictericia, las telangiectasias, los angiomas en araña, el eritema palmar, los xantomas y los xantelasmas, entre otras.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Longo DL, Fauci AS, Hauser SL, Jameson JL, Loscalzo J. Cardinal manifestations and presentation of diseases: alterations in the skin. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al., eds. Harrison’s Principles of Internal Medicine (ed 18). New York: Mc Graw Hill; 2011.

  2. Mela M, Mancuso A, Burroughs AK. Review article: pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther 2003; 17: 857-870.

  3. Ghosn SH, Kibbi AG. Cutaneous manifestations of liver diseases. Clin Dermatol 2008; 26: 274-282.

  4. Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician 2004; 69: 299-304.

  5. Perilla O. Enfoque diagnóstico del paciente ictérico. Memorias del XII Curso de Residentes de Medicina Interna de la Universidad de Antioquia. Medellin: Artes y Letras Ltda; 2009: 327-339.

  6. Dusol M, Jr., Schiff ER. Clinical approach to jaundice. Postgrad Med 1975; 57: 118-124.

  7. de Zubiría R. Clínica de las ictericias. Revista de la Facultad de Medicina 1955; 23: 275- 299.

  8. Winger J, Michelfelder A. Diagnostic approach to the patient with jaundice. Prim Care 2011; 38: 469- 482; viii.

  9. Failache O. Ictericia neonatal. Arch Pediatr Urug 2002; 73: 143-145.

  10. Ebbesen F. The relationship between the cephalo-pedal progress of clinical icterus and the serum bilirubin concentration in newborn infants without blood type sensitization. Acta Obstet Gynecol Scand 1975; 54: 329-332.

  11. Keren R, Tremont K, Luan X, Cnaan A. Visual assessment of jaundice in term and late preterm infants. Arch Dis Child Fetal Neonatal Ed 2009; 94: F317- 322.

  12. American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.

  13. Kremer AE, Oude Elferink RP, Beuers U. Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol 2011; 35: 89-97.

  14. Levy C. Management of pruritus in patients with cholestatic liver disease. Gastroenterol Hepatol (NY) 2011; 7: 615-617.

  15. Bergasa NV. The pruritus of cholestasis. J Hepatol 2005; 43: 1078-1088.

  16. Kremer AE, Martens JJ, Kulik W, Rueff F, Kuiper EM, van Buuren HR, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010; 139: 1008-1018, 1018 e1001.

  17. Oude Elferink RP, Kremer AE, Martens JJ, Beuers UH. The molecular mechanism of cholestatic pruritus. Dig Dis 2011; 29: 66-71.

  18. Matterne U, Apfelbacher CJ, Loerbroks A, Schwarzer T, Buttner M, Ofenloch R, et al. Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study. Acta Derm Venereol 2011; 91: 674-679.

  19. Kremer AE, Maillette de Buy Wenniger L, Oude Elferink RP, Beuers U. [Pruritus in liver disease. Pathogenesis and treatment]. Ned Tijdschr Geneeskd 2011; 155: A4045.

  20. Johnston G, Graham R. Manifestaciones cutáneas de trastornos de órganos internos. In: Callen JP, Jorizzo JL, eds. Signos cutáneos de las enfermedades sistémicas (ed 4). España: Elsevier Saunders; 2011.

  21. Li CP, Lee FY, Hwang SJ, Chang FY, Lin HC, Lu RH, et al. Role of substance P in the pathogenesis of spider angiomas in patients with nonalcoholic liver cirrhosis. Am J Gastroenterol 1999; 94: 502-507.

  22. Li CP, Lee FY, Hwang SJ, Chang FY, Lin HC, Lu RH, et al. Spider angiomas in patients with liver cirrhosis: role of alcoholism and impaired liver function. Scand J Gastroenterol 1999; 34: 520-523.

  23. Hazin R, Abu-Rajab Tamimi TI, Abuzetun JY, Zein NN. Recognizing and treating cutaneous signs of liver disease. Cleve Clin J Med 2009; 76: 599-606.

  24. Li CP, Lee FY, Hwang SJ, Lu RH, Lee WP, Chao Y, et al. Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor. World J Gastroenterol 2003; 9: 2832-2835.

  25. Foutch PG, Sullivan JA, Gaines JA, Sanowski RA. Cutaneous vascular spiders in cirrhotic patients: correlation with hemorrhage from esophageal varices. Am J Gastroenterol 1988; 83: 723-726.

  26. Haitjema T, Westermann CJ, Overtoom TT, Timmer R, Disch F, Mauser H, et al. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment. Arch Intern Med 1996; 156: 714-719.

  27. Nabatian A, Suchter MF, Milgraum S. Palmar telangiectases as a manifestation of Graves disease. Cutis 2012; 89: 84-88.

  28. Serrao R, Zirwas M, English JC. Palmar erythema. Am J Clin Dermatol 2007; 8: 347-356.

  29. Okumura H, Aramaki T, Katsuta Y, Terada H, Satomura K, Akaike M, et al. Regional differences in peripheral circulation between upper and lower extremity in patients with cirrhosis. Scand J Gastroenterol 1990; 25: 883-889.

  30. Colle I, Geerts AM, Van Steenkiste C, Van Vlierberghe H. Hemodynamic changes in splanchnic blood vessels in portal hypertension. Anat Rec (Hoboken) 2008; 291: 699-713.

  31. Kim MY, Baik SK, Lee SS. Hemodynamic alterations in cirrhosis and portal hypertension. Korean J Hepatol 2010; 16: 347-352.

  32. Pegot N. Tumeur variqueuse avec anomalie du systeme veineux et persistance de la veine ombilicale developpement des veins souscutanees abdominales. Bull Soc Anat 1833; 8: 57.

  33. Cruveilhier J. Anatomie pathologique du corps humain. JB Bailliere 1835.

  34. Von Baumgarten P. Uebervoll standiges Offenbleiben der Vena umbilicalis; zugleich ein Beitrag zur Frage des Morbus Bantii. Arb Geb Pathol Anat Int Tubingen 1908; 6: 93-110.

  35. Longo M, Crosignani A, Battezzati PM, Squarcia Giussani C, Invernizzi P, Zuin M, et al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 2002; 51: 265-269.

  36. Allocca M, Crosignani A, Gritti A, Ghilardi G, Gobatti D, Caruso D, et al. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut 2006; 55: 1795-1800.

  37. McIntyre N, Harry DS, Pearson AJ. The hypercholesterolaemia of obstructive jaundice. Gut 1975; 16: 379-391.

  38. Otto AI, Horvath I, Feldmann J. Multiple firm, painless erythematous papules with a yellowish hue. Arch Dermatol 2005; 141: 1595-1600.

  39. Love JR, Dubin HV. Xanthomas and lipoproteins. Cutis 1978; 21: 801-805.

  40. Parker F. Xanthomas and hyperlipidemias. J Am Acad Dermatol 1985; 13: 1-30.

  41. Lugo-Somolinos A, Sanchez JE. Xanthomas: a marker for hyperlipidemias. Bol Asoc Med P R 2003; 95: 12-16.

  42. Braunstein GD. Gynecomastia. N Engl J Med 1993; 328: 490-495.

  43. Kapoor S. Cutaneous manifestations of systemic conditions associated with gynecomastia. Skinmed 2010; 8: 87-92; quiz 92.

  44. Cavanaugh J, Niewoehner CB, Nuttall FQ. Gynecomastia and cirrhosis of the liver. Arch Intern Med 1990; 150: 563-565.

  45. Jerosch-Herold C, Shepstone L, Chojnowski AJ, Larson D. Splinting after contracture release for Dupuytren’s contracture (SCoRD): protocol of a pragmatic, multi-centre, randomized controlled trial. BMC Musculoskelet Disord 2008; 9: 62.

  46. Bertrand J, Thomas J, Metman EH. [Dupuytren’s contracture and palmar erythema in alcoholic cirrhosis]. Sem Hop 1977; 53: 407-412.

  47. Noble J, Arafa M, Royle SG, McGeorge G, Crank S. The association between alcohol, hepatic pathology and Dupuytren’s disease. J Hand Surg Br 1992; 17: 71-74.

  48. Dogra S, Jindal R. Cutaneous manifestations of common liver diseases. J Clin Exp Hepatol 2011; 1: 177- 184.

  49. Holzberg M, Walker HK. Terry’s nails: revised definition and new correlations. Lancet 1984; 1: 896-899.

  50. Terry R. White nails in hepatic cirrhosis. Lancet 1954; 266: 757-759.

  51. American Society for the Surgery of the Hand. Hand and arm conditions. Systemic diseases. 2011. http://www.assh.org/PUBLIC/HANDCONDITIONS/ Pages/SystemicDiseases.aspx Consultado el 14 de mayo de 2012.




2020     |     www.medigraphic.com